<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04841837</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00006761-M2021024</org_study_id>
    <nct_id>NCT04841837</nct_id>
  </id_info>
  <brief_title>Effect of Time-restricted Eating on Blood Glucose and Behavior in Patients With Type 2 Diabetes Mellitus</brief_title>
  <acronym>TREAT BB</acronym>
  <official_title>Effect of Time-restricted Eating on Blood Glucose and Behavior in Patients With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diet management could improve blood and weight control in patients with diabetes mellitus.&#xD;
      Time-restricted feeding is a novel dietary tool that limits time of energy intake without&#xD;
      altering diet quality or quantity. This study aims to assess the effect of 10-hour&#xD;
      time-restricted feeding on metabolism and behavior in patients with type 2 diabetes mellitus.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean blood glucose</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time in range</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compliance of time-restricted feeding</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
    <description>Percent of days when the participants follow 10-hours window of calorie intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type and proportion of intestinal flora</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
    <description>Collect fecal specimens, analyze the types and proportion of intestinal flora</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight (kg)</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
    <description>Electronic weighing scale will be used to weigh participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (fat and muscle mass)</measure>
    <time_frame>through study completion, an average of 12 weeks</time_frame>
    <description>Body composition analyzer will be used to analyze fat and muscle mass</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Time-restricted feeding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Restrict all calorie intake within a self-selected 10-hours window for 12 weeks, without necessarily altering diet quality and quantity</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Time-restricted feeding</intervention_name>
    <description>limit daily food intake to a period of 10 hours</description>
    <arm_group_label>Time-restricted feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed with type 2 diabetes mellitus&#xD;
&#xD;
          2. HbA1c 7.0% to 8.5%&#xD;
&#xD;
          3. BMI ≥ 24 kg/m2&#xD;
&#xD;
          4. Time of energy intake ≥ 12 hours per day, ≥ 4 days per week&#xD;
&#xD;
          5. Ability to use smart phone and app, to follow study protocol&#xD;
&#xD;
          6. Sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Use insulin, long-acting insulin secretagogues, GLP-1 receptor agonist, DPP-4&#xD;
             inhibitor, SGLT-2 inhibitor&#xD;
&#xD;
          2. Suffer from disease influence eating: mental disease, subtotal gastrectomy,&#xD;
             inflammatory bowel disease, uncontrolled thyroid disease&#xD;
&#xD;
          3. Work state affect eating time: constant night duty, constant long-haul international&#xD;
             travel&#xD;
&#xD;
          4. Smoking&#xD;
&#xD;
          5. Drinking&#xD;
&#xD;
          6. Severe disease: severe cardiovascular and cerebrovascular disease, uncontrolled&#xD;
             arrhythmia, heart failure, acute and chronic renal dysfunction, liver cirrhosis,&#xD;
             malignancy, anemia&#xD;
&#xD;
          7. Suffered from infectious disease: pulmonary tuberculosis, AIDS&#xD;
&#xD;
          8. Dyskinesia&#xD;
&#xD;
          9. Body weight change ≥ 5 kg in the past 3 months&#xD;
&#xD;
         10. Hospitalized in the past 3 months&#xD;
&#xD;
         11. Used antibiotics for ≥ 3 days in the past 3 months&#xD;
&#xD;
         12. Diagnosed with type 1 diabetes mellitus&#xD;
&#xD;
         13. Pregnancy, lactating&#xD;
&#xD;
         14. Participating in other clinical trials in the past 1 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Haining Wang</last_name>
    <phone>010-82266920</phone>
    <email>hainingmail@bjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei Fu</last_name>
    <phone>010-82266920</phone>
    <email>fuweiputh@bjmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kun Yang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 6, 2021</study_first_submitted>
  <study_first_submitted_qc>April 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Time-restricted feeding</keyword>
  <keyword>Type 2 diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

